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Background: The oral cavity is the store house of different species of microorganisms that are continuously
engaged in causing diseases in the mouth. The present study was conducted to evaluate the antibacterial potential
of crude extracts of the aerial parts of Phytolacca americana and its natural compounds against two oral pathogens,
Porphyromonas gingivalis and Streptococcus mutans, which are primarily responsible for periodontal inflammatory
diseases and dental caries, as well as a nonpathogenic Escherichia coli.
Methods: Crude extract and fractions from the aerial parts of P. americana (0.008–1.8 mg/mL) were evaluated for
their potential antibacterial activity against two oral disease causing microorganisms by micro-assays. The standard
natural compounds present in P. americana, kaempferol, quercetin, quercetin 3-glucoside, isoqueritrin and ferulic
acid, were also tested for their antibacterial activity against the pathogens at 1–8 μg/mL.
Results: The crude extract was highly active against P. gingivalis (100% growth inhibition) and moderately active
against S. mutans (44% growth inhibition) at 1.8 mg/mL. The chloroform and hexane fraction controlled the growth
of P. gingivalis with 91% and 92% growth inhibition at a concentration of 0.2 mg/mL, respectively. Kaempferol
exerted antibacterial activity against both the pathogens, whereas quercetin showed potent growth inhibition
activity against only S. mutans in a concentration dependent manner.
Conclusion: The crude extract, chloroform fraction, and hexane fraction of P. americana possesses active natural
compounds that can inhibit the growth of oral disease causing bacteria. Thus, these extracts have the potential for
use in the preparation of toothpaste and other drugs related to various oral diseases.
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The mouth cavity contains many microorganisms respon-
sible for various infections and inflammatory diseases [1].
The most common types of pathological diseases in the
mouth are periodontal diseases and dental caries [2]. These
diseases are caused by various plaque forming bacteria such
as Streptococcus mutans, Porphyromonas gingivalis, Prevo-
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unless otherwise stated.[2-4], which reside in the oral cavity. Periodontal disease is
a common inflammatory disease inside the oral cavity
caused by a complex biofilm of periodontopathic and resi-
dent commensal bacteria species that form an integral part
of the disease along with the environment and host related
factors [5,6]. Periodontal diseases are primarily caused
by a group of anaerobic Gram-negative bacteria including
P. gingivalis, P. intermedia, Actinobacillus and Fusobacter-
ium sp. [4]. The formation of dental caries is caused by the
accumulation and colonization of oral microorganisms,
especially S. mutans [3], which adhere to and colonize the
surface of teeth, as well as to other oral bacteria that caused. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lus sp. and Prevotella sp. [2,3].
Dental treatments in many countries are expensive
and not easily accessible; therefore, people have turned
to the use of medicinal plants in the form of compos-
ition of tooth paste, or simply chewing the plants
directly to protect the teeth from diseases [7,8]. Different
plant species of medicinal importance have successfully
been included in mouthwashes and toothpastes in many
developing countries [1,9,10]. Moreover, public research
programs and dental care companies are screening
medicinal plants and their extracts for their ability to
control the pathogens P. gingivalis and S. mutans, which
are the root cause of most oral cavity diseases.
Phytolacca americana L., which is commonly known
as tropical pokeweed, belongs to the family Phytolacca-
ceae. P. americana L. is an herbaceous perennial plant
distributed throughout most of North and South
America, Africa and Asia [11,12]. Because of their anti-
microbial, anti-inflammatory, anticancer and stimula-
tory effects, herbal preparations of this plant have been
used extensively in traditional medicines in South and
Central America for the treatment of many disorders
including glandular swelling with heat and inflammation,
syphilitic bone pain, sore throat, quinsy and diphtheria
[11,13,14]. The use of this plant in herbal medicine is
typically based on its folklore and traditional evidence.
Scientific evidence on the medicinal potential and some
types and nature of bioactive compounds present in this
plant has been reported [12].
In the process of performing research on screening of
various medicinal effects of invasive plants in the Republic
of Korea funded by the National Institute of Biological
Resources (NIBR, www.nibr.go.kr), the overwhelming anti-
bacterial potential of the extracts of P. americana against
the oral pathogens P. gingivalis and S. mutans were evalu-
ated. In this study, therefore, various experiments investi-
gating a range of concentrations of crude extract from P.
americana and the individual fractions were conducted to
evaluate the potential for development of new natural
antibacterial medicines without affecting the normal
microflora of the mouth cavity by testing the antibacterial
effect of the extract on nonpathogenic Escherichia coli.
Methods
Preparation of crude extract of P. americana
The aerial parts (leaves and soft stem) of the wild herb
P. americana were collected from the local area of
Inchean (Sindori, Wongjin-gun, Inchon, Korea) during
June 2013. Accurate identification of P. americana was
conducted by an experienced taxonomist Jeong-Eun
Han, and specimens were stored at the Natural Products
Bank, Wildlife Genetic Resources Center at the NIBR
(voucher number NIBRVP0000413856). The plant partswere washed twice with tap water and then dried in an
oven for 3 days at 40°C. Following drying, samples were
chopped into small pieces (about 2.5 cm) using a straw
cutter, after which 500 g of dried pieces were extracted
in 80% methanol using an ultrasonic apparatus. The
solvent was removed under vacuum, and 17.24% is the
yield of the extract. This methanolic extract was further
suspended in H2O, then partitioned successively with
n-hexane, chloroform, ethanol, and n-butanol [15]. All
crude extract and fractions were passed through a
nylon membrane filter (0.2 μm pore size), freeze-dried,
dissolved in 5% dimethyl sulfoxide (DMSO) and stored
at −20°C freezer until further use. All chemicals used in
this experiment were of analytical grade and purchased
from Sigma-Aldrich (St. Louis, USA).
Screening of antibacterial activity of P. americana
Two oral pathogenic bacteria, P. gingivalis W83 (ATCC
BAA-1703™) and S. mutans UA159 (ATCC 700610™), and
one nonpathogenic bacterium, E. coli DH5α, used in the
study were procured from the American Type Culture
Collection (ATCC). P. gingivalis and S. mutans were
cultured anaerobically in brain-heart infusion broth media
supplemented with hemin and menadione and tryptic soy
broth media, respectively [16,17], and E. coli DH5α strain
was cultured in Luria-Bertuni (LB) broth media.
The antibacterial activity was evaluated by standard
micro-assays using conventional sterile polystyrene micro-
plates [18]. The assay mixture contained 50 μL of inocula
and 50 μL of the tested extract/fraction/compounds at
different concentrations (0.2–1.8/0.008–0.2 mg/mL and
1–8 μg/mL) respectively. Additionally, 50 μL of media
with 50 μL of inoculum was used as a control and
50 μL of media with 50 μL of 5% DMSO was used as
solvent control. All experiments were repeated three times
and all concentrations of the extract and compounds were
measured in triplicate. The natural compounds included
kaempferol, quercetin, quercetin 3-glucoside, isoquercitrin
and ferulic acid. The microplates were incubated at 37°C
for 24 h, and the growth of bacteria was determined by
measuring the optical density (OD) at 630 nm using an
ELISA microplate reader (FilterMax F5 multi-mode mi-
croplate reader, Molecular Devices, Sunnyvale, CA, USA).
Minimum inhibitory concentration (MIC) of the extract
was taken as the lower concentration of the extract show-
ing no visible growth of the organism. Finally, the percent-
age of bacterial growth inhibition (GI) was calculated
using the following formula:
GI% ¼ CAbs − TAbsð Þ=CAbs½   100
Where CAbs is the absorbance of the control treatment
and TAbs is the absorbance of samples treated with
different extracts.
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All experiments were conducted three times and the re-
sults were expressed as the means of three samples ± the
standard deviation (SD). Analysis of the variance was de-
termined by Duncan's test using the Statistical Analysis
Software (SAS) version 9.2 (SAS Inc., Cary, USA).
Results
The bactericidal effects of the crude extract and different
fractions of the extracts of P. americana were evaluated
against two oral pathogenic bacteria, P. gingivalis and S.
mutans, and one nonpathogenic bacteria, E. coli DH5α
(Table 1). At the highest concentration used (1.8 mg/mL),
the crude extract was very active against P. gingivalis
(100% growth inhibition) and moderately active against S.
mutans (44% growth inhibition) (Table 1). However, the
crude extract inhibited only 6% of the growth of E. coli
DH5α at the same concentration (Table 1). After further
decrease in the concentration of the crude extract by three
and five times (0.6 or 0.2 mg/mL, respectively), significant
suppression of the growth of P. gingivalis by 100 or 88%,
respectively, was still observed. The crude extract showed
low antibacterial activity against S. mutans and E. coli
DH5α at the same concentrations (Table 1).
After measuring the activity of crude extract from





Crude extract 0.2 mg/mL 88 ± 1
0.6 mg/mL 100 ±
1.8 mg/mL 100 ±
MIC 0.2 mg
Hexane Fr. 0.008 mg/mL 0 ± 0.0
0.04 mg/mL 26 ± 2
0.2 mg/mL 92 ± 0
MIC 0.2 mg
CHCl3 Fr. 0.008 mg/mL 0 ± 0.0
0.04 mg/mL 0 ± 0.0
0.2 mg/mL 91 ± 2
MIC 0.2 mg
EtOAc Fr. 0.008 mg/mL 0 ± 0.0
0.04 mg/mL 0 ± 0.0
0.2 mg/mL 46 ± 5
BuOH Fr. 0.008 mg/mL 0 ± 0.0
0.04 mg/mL 0 ± 0.0
0.2 mg/mL 4 ± 1.5
*Data are expressed as the mean ± SD.
#Values in the same column with different superscript letters are significantly differefurther fractioned using four different solvents. When
the fractions were tested at 0.2 mg/mL, the hexane and
chloroform fraction significantly suppressed the growth of
P. gingivalis by 92% and 91%, respectively. When the con-
centration was further diluted by five times (0.04 mg/mL),
the antibacterial effects of the hexane and chloroform
fractions against P. gingivalis decreased significantly to
26% and 0%, respectively. Evaluation of the extract of
P. americana revealed that the hexane and chloroform
fractions inhibited the growth of S. mutans by 62% and
56%, respectively, at 0.2 mg/mL. However, the fractions
did not exert an antibiotic effect on E. coli DH5α (Table 1).
The antibacterial effects of some selected natural com-
pounds in P. americana L. such as kaempferol, quercetin,
quercetin 3-glucoside, isoquercitrin and ferulic acid were
also tested at different concentrations (1–8 μg/mL) against
the two oral pathogenic and one non-pathogenic bacteria.
Only kaempferol displayed higher antibacterial effects
against both P. gingivalis and S. mutans and low activity
against E. coli (Figure 1). At 8 μg/mL, kaempferol exhibited
84% antibacterial activity against P. gingivalis, which was
reduced to 38% when the concentration of the compound
was, diluted two times (Figure 1). Further dilution resulted
in loss of activity of the compound against the pathogen.
Similarly, kaempferol showed 97% and 45% growth inhib-
ition against S. mutans at 8 μg/mL and 4 μg/mL,f Phytolacca americana against the tested bacteria
givalis S. mutans E. coli DH5α
th inhibition (%)
9.06b*# 13 ± 21.66yz 2 ± 3.94
0.39a 35 ± 25.01xy 3 ± 3.20
0.41a 44 ± 35.29x 6 ± 4.45
/mL 1.8 mg/mL -
0e 2 ± 16.46z 0 ± 0.00
.36d 0 ± 0.00z 0 ± 0.00
.56ab 62 ± 1.49x 0 ± 0.00
/mL 0.2 mg/mL -
0e 0 ± 0.00z 0 ± 0.00
0e 0 ± 0.00z 0 ± 0.00
.00ab 56 ± 10.52x 0 ± 0.00
/mL 0.2 mg/mL -
0e 0 ± 0.00z 7 ± 1.90
0e 1 ± 0.00z 2 ± 1.38
.63c 0 ± 0.00z 0 ± 0.00
0e 0 ± 0.00z 10 ± 0.83
0e 0 ± 0.00z 6 ± 1.05
5e 0 ± 0.00z 0 ± 0.00

















































































Figure 1 Antibacterial activity of the natural compounds
present in Phytolacca americana against the tested bacteria.
(A) Porphyromonas gingivalis; (B) Streptococcus mutans; (C) Escherichia
coli DH5α strain. Different letters on the bars are significantly different
at p < 0.001.
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inhibition against S. mutans at 8 μg/mL, but no effect
was observed against P. gingivalis at any of the tested
concentrations.
Quercetin 3-glucoside and isoqueritrin showed very lit-
tle growth inhibition activity against S. mutans and no ac-
tivity against the other tested organisms (Figure 1). None
of the natural compounds of the plant exerted significant
inhibition activity against the nonpathogenic E. coli.
Discussion
Human pathogenic microorganisms have developed resist-
ance to drugs owing to the extensive use of commercial
synthetic antibacterial drugs in large quantity without
proper medical prescriptions and tests. This condition has
raised alarm in most developed and developing countries
and the scientists are forced to search an alternative tothese compounds, often in the form of natural medicines
from resources such as plants. It is well known that
in vitro evaluation of plant species with ethno-medicinal
potential is the first step towards development of a new
eco-friendly and effective drug against any type of infec-
tious disease. In the present study, a similar attempt
was made to search for potential bioactive compounds
from P. americana for treatment of various periodontal
inflammatory diseases and dental caries that are caused
by pathogenic anaerobic bacteria (P. gingivalis and
S. mutans). Crude extract of P. americana inhibited the
growth of P. gingivalis by 100% at 1.8 and 0.6 mg/mL
(Table 1). Even diluted concentrations of 0.2 mg/mL
inhibited growth by 88%. Additionally, crude extract
exerted moderate effects of 44% and 35% on S. mutans
at 1.8 and 0.6 mg/mL (Table 1), while it had very low
activity against non-pathogenic E. coli.
With an aim to identify the active fraction in which
most of the antibacterial compounds are separated, the
crude methanol extract was fractioned using hexane,
chloroform, ethanol and butanol and then tested against
the three aforementioned bacteria. Among all the frac-
tions, hexane and chloroform fractions showed greater
inhibition of the growth of P. gingivalis and S. mutans
(Table 1). Significant antibacterial activity of the fraction
against P. gingivalis might have been due to the fact that
the natural bioactive compounds responsible for the
antibacterial activity are mostly extracted in both the
solvents and these active compounds may be able to
penetrate the thick cell walls through general diffusion
channels formed by the bacterial porins present therein
[2,7,19,20], and affect the bacterial enzymes like gingi-
pain that are responsible for survival and virulence of
P. gingivalis [21,22] resulting in cellular lysis. However
these extracts do not affect the non-pathogenic bacteria
which may be due to hindrance of penetration through
the outer cell wall and absence of specific enzyme in the
bacteria. This mode of action of the plant extract against
the specific bacteria may be due to its secondary mode
of action against the bacterial enzymes instead of acting
on the cell wall of the bacteria [21,22].
Five most important natural compounds present in
P. americana with possible antibacterial properties were
selected and evaluated for their antibacterial activity
against oral pathogens. Kaempferol showed significant
antibacterial activity against both the oral pathogens in
a concentration dependent manner (Figure 1), whereas
only quercetin showed potent growth inhibition activity
against S. mutans. This might have been due to easy
penetration of the quercetin molecule into the Gram
positive bacterial cells of S. mutans, resulting in disrup-
tion of the cell wall and cytoplasmic membrane [23].
Compounds such as kaempferol have previously been
reported to exhibit inhibitory activity against oral
Patra et al. BMC Complementary and Alternative Medicine 2014, 14:343 Page 5 of 6
http://www.biomedcentral.com/1472-6882/14/343pathogens [24,25]. Cai and Wu [26] demonstrated the
potent growth-inhibitory activity of kaempferol against
the periodontal pathogens P. gingivalis and P. inter-
media. Liberio et al. [27] also reported that the active
compound present in geopropolis produced by the
stingless bee, Melipona fasciculate Smith and that
possess antibacterial activity against oral pathogens is
Quercetin. Similar effects of quercetin on oral infectious
pathogens were also reported by Shu et al. [28]. The
crude extract and its fractions exerted potent activity
against bacterial pathogens relative to the pure natural
compounds, suggesting synergistic properties of com-
pounds that display promising antibiotic results in
mixture and lose its activity when applied individually.
The antibacterial effects of the plant extract justified its
ethnomedicinal uses in traditional medicine [11,14,29,30].
Similar investigations of the use of plants for the treat-
ment of oral cavity infections have also been reported
[2,31]. Additionally, the plant extract and its fractions
were not very effective at inhibiting the nonpathogenic
bacteria, E. coli DH5α, which indicates that, use of the
plant extract as medicine or in toothpaste will only affect
oral pathogenic bacteria, and not the normal flora of the
mouth cavity.
Conclusions
Herbal plant extracts are a rich source of natural chem-
ical compounds that have been utilized in various appli-
cations on the basis of their biological activities. Active
compounds present in plants have shown positive results
against oral pathogenic microbes and can thus facilitate
management of various inflammatory diseases related to
the mouth and dental caries. The present study is a pre-
liminary attempt to investigate the antibacterial proper-
ties of aerial parts of P. americana against P. gingivalis
and S. mutans. Based on the results of the present study,
the plant fractions can be used in herbal toothpaste and
medicine for the treatment of periodontal disease and
dental caries. However, further research is needed to
identify and characterize the active molecules respon-
sible for their antibacterial properties and to determine
its potential for use in pharmaceutical industries.
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